Literature DB >> 10555028

Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids.

D D Sherry1, L D Stein, A M Reed, L E Schanberg, D W Kredich.   

Abstract

OBJECTIVE: To determine if intraarticular (i.a.) injection of triamcinolone hexacetonide (steroids) used early in the course of pauciarticular juvenile rheumatoid arthritis (pauci JRA) is associated with less leg length discrepancy (LLD) or thigh circumference discrepancy (TCD).
METHODS: Children with pauci JRA who had asymmetric lower-extremity arthritis diagnosed before age 7 years in Seattle, Washington (WA; n = 16) and in Chapel Hill and Durham, North Carolina (NC; n = 14) were retrospectively identified. WA children were given i.a. steroids within 2 months of diagnosis; the injections were repeated if synovitis recurred in the same joint or in a different joint. These children were compared with NC children who were not treated with i.a. steroids. Thigh circumference was measured at 10 cm above the patella, and leg length was measured from the anterior superior iliac spine to the mid-medial malleolus, by a single observer. LLD and TCD are reported as the percentage of difference between leg measurements in each subject.
RESULTS: The WA and NC subjects had comparable disease severity and duration of followup (in months). Twelve WA children had subsequent i.a. steroid injections (mean 3.25 injections per child over mean +/- SD 42 +/- 11 months). The WA subjects had significantly less LLD (P = 0.005, by Student's 2-sided t-test) and prescriptions for shoe lifts (P = 0.002, by Fisher's 2-sided exact test). There was not a significant difference in TCD between the 2 groups (P = 0.139, by Student's 2-sided t-test). Similar findings were obtained when the analysis was limited to children with monarticular knee arthritis.
CONCLUSION: Early and continued use of i.a. steroids may be associated with less LLD in young children with pauci JRA. This may indicate decreased duration of synovitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555028     DOI: 10.1002/1529-0131(199911)42:11<2330::AID-ANR11>3.0.CO;2-B

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

2.  Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis.

Authors:  Peter Marti; Luciano Molinari; Isabel B Bolt; Reinhard Seger; Rotraud K Saurenmann
Journal:  Eur J Pediatr       Date:  2007-06-12       Impact factor: 3.183

3.  Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm(2)) ultrasound exposure on carrageenan-induced arthritis in a mouse model.

Authors:  Gadi Cohen; Hiba Natsheh; Youhan Sunny; Christopher R Bawiec; Elka Touitou; Melissa A Lerman; Philip Lazarovici; Peter A Lewin
Journal:  Ultrasound Med Biol       Date:  2015-05-21       Impact factor: 2.998

4.  The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy.

Authors:  Annemarie C Brescia; Megan M Simonds; Suzanne M McCahan; Paul T Fawcett; Carlos D Rose
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

5.  Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital.

Authors:  Olivia Min Yi Leow; Lee Kean Lim; Pei Ling Ooi; Lynette Pei Chi Shek; Elizabeth You Ning Ang; Mary Beth Son
Journal:  Singapore Med J       Date:  2014-05       Impact factor: 1.858

Review 6.  US Evaluation of Juvenile Idiopathic Arthritis and Osteoarticular Infection.

Authors:  Jie C Nguyen; Kenneth S Lee; Mahesh M Thapa; Humberto G Rosas
Journal:  Radiographics       Date:  2017 Jul-Aug       Impact factor: 5.333

Review 7.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

8.  A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.

Authors:  Mehrzad Hajialilo; Amir Ghorbanihaghjo; Leyla Valaee; Sousan Kolahi; Naderh Rashtchizadeh; Maryam Bannazadeh Amirkhiz; Ida Malekmahdavi; Alireza Khabbazi
Journal:  Clin Rheumatol       Date:  2016-08-29       Impact factor: 2.980

9.  Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA.

Authors:  Gordon J Hendry; Deborah E Turner; John McColl; Paula K Lorgelly; Roger D Sturrock; Gordon F Watt; Michael Browne; Janet Gardner-Medwin; Lorraine Friel; Jim Woodburn
Journal:  J Foot Ankle Res       Date:  2009-06-30       Impact factor: 2.303

10.  The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic.

Authors:  Sarah Ringold; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2009-05-29       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.